EBOS investment in MedAdvisor
1
EBOS Group Limited. NZBN 9429031998840
Level 7, 737 Bourke Street, Docklands, Victoria 3008, Australia. PO Box 7300, Melbourne, Victoria 8004, Australia.
Phone: +61 3 9918 5555, Fax: +61 3 9918 5588.
www.ebosgroup.com
24 October 2017 NZX/ASX Code: EBO
EBOS acquires cornerstone shareholding in MedAdvisor
EBOS is pleased to announce that it has made an investment of A$10.5 million to acquire a
strategic 14.1% shareholding in Australia’s leading digital medication management
company, MedAdvisor Limited (ASX: MDR).
MedAdvisor’s software system has wide customer acceptance with over 900,000 users and
is connected to over 2,600 Australian pharmacies.
EBOS' investment is part of a wider partnership with MedAdvisor that will seek to advance
the commercial interests of both organisations by increasing the availability of digital health
applications across EBOS' community pharmacy and institutional healthcare businesses.
For further information, please contact:
Mark Connell
Group Investor Relations Manager
EBOS Group Limited
+61 402 995 519
About EBOS Group
EBOS Group Limited (NZX/ASX Code: EBO) is the largest and most diversified Australasian
marketer, wholesaler and distributor of healthcare, medical and pharmaceutical products. It
is also a leading Australasian animal care products marketer and distributor.
Data sourced from publicly available filings. Our datasets may not be complete. Automated analysis can produce errors. If you believe any data on this page is incorrect, please contact us at hello@nzxplorer.co.nz. For informational purposes only. Not investment advice.
Other issuers discussed similar conditions around this time
Matched by meaning across NZX announcement text, not keywords — based on our semantic index of announcement bodies.
- ERD — EROAD: EROAD LIMITED SUCCESSFULLY COMPLETES EQUITY RAISING2017-12-12
“eroad.co.nz NZX Release EROAD LIMITED SUCCESSFULLY COMPLETES EQUITY RAISING 13 December 2017 EROAD Limited (NZX: ERD) (EROAD) is pleased to announce it has successfully raised approximately NZ$15.5 million through its placement announced on 12 December 2017…”
- ERD — EROAD: EROAD achieves record sales in New Zealand and US markets2017-11-27
“3 meet the December 2017 deadline are urgently seeking a solution, and tend to be price rather than value focused. Fleets whose vehicles already have an automatic on-board recording device (AOBRD) have two years’ grace (18 December 2019), and these operators are looking for…”
- ENS — Enprise Group Limited: Investor Notice -Half Year 30 Sep 20172017-11-30
“Enprise Group is a public company listed on New Zealand’s NZAX stock exchange with the code ENS. 1 01 December 2017 Enprise Group reports 22 percent profit increase in half year results AUCKLAND. Enprise Group (NZAX: ENS) today reported strong year-on-year growth in re…”